Confronting Illusions of Quality in Indian Generics Manufacturing

A sharp increase in data integrity findings has raised questions about the quality of pharmaceutical manufacturing in India. What’s happening and why, who’s responsible, and how can drug makers and the regulatory agencies that watch over them put a stop to it?

More from Manufacturing

More from Compliance